Zosano Pharma Corporation (ZSAN) Issues Earnings Results
Zosano Pharma Corporation (NASDAQ:ZSAN) posted its quarterly earnings data on Thursday. The biotechnology company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.05), Bloomberg Earnings reports.
Shares of Zosano Pharma Corporation (ZSAN) opened at $0.70 on Friday. Zosano Pharma Corporation has a 12 month low of $0.48 and a 12 month high of $3.54.
An institutional investor recently raised its position in Zosano Pharma Corporation stock. Vanguard Group Inc. raised its stake in shares of Zosano Pharma Corporation (NASDAQ:ZSAN) by 20.8% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,217,323 shares of the biotechnology company’s stock after purchasing an additional 209,251 shares during the period. Vanguard Group Inc. owned 3.11% of Zosano Pharma Corporation worth $1,716,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 22.66% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This report was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/11/10/zosano-pharma-corporation-zsan-issues-earnings-results.html.
Separately, ValuEngine upgraded Zosano Pharma Corporation from a “strong sell” rating to a “sell” rating in a research note on Friday, September 1st.
Zosano Pharma Corporation Company Profile
Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability.
Receive News & Stock Ratings for Zosano Pharma Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zosano Pharma Corporation and related stocks with our FREE daily email newsletter.